Observational studies have found that plasma taurine concentrations tend to be lower in those with diabetes compared to non-diabetic controls (Franconi 1994
G., Haftek, M., Creidi, P., Lapire, C., Nusgens, B., Richard, A., Schmitt, D., Rougier, A., & Zahouani, H
In preclinical models, GIP has been shown to decrease food intake and increase energy expenditure therefore resulting in weight reductions, and when combined with GLP-1 receptor agonist, may result in greater effects on markers of metabolic dysregulation such as body weight, glucose and lipids. How do drugs like Wegovy and Mounjaro work
BPC-157 helps reduce inflammation associated with chronic injuries, autoimmune conditions, and ongoing physical stressgiving your body a chance to calm down and recover